PJ view: Private COVID-19 vaccines should be welcomed with caution
As pharmacies prepare to offer private COVID-19 vaccinations, cost considerations must be made to ensure this does not become a step towards wider health inequality.…
News
See all-
More than 5,000 patients treated for ear problems under community pharmacy pilot
-
First drug for severe alopecia recommended by NICE could benefit 14,000 patients
-
GPhC considers new registration routes that would enable overseas pharmacists to work in Great Britain more quickly
-
Allowing pharmacy technicians to supervise hospital aseptic facilities would increase risk of ‘catastrophic clinical error’, says PDA
-
UK regulator recommends new safety measures for medicines containing pseudoephedrine
Sign in now if you’re an RPS member or subscriber.
Become a member of the RPS or subscribe to gain unlimited access.
Cipro Best Price
Pharmacy technicians could supply naloxone without prescription under government proposals
Pharmacy regulator consults on draft standards for chief pharmacists
Welsh Pharmacy Board Election 2024
Pilot scheme explores value of protected learning time for pharmacist independent prescribers
RPS calls for review of the medicines supply chain in its general election manifesto
Minor ailments consultations in community pharmacies increase by almost three-quarters in a year
Pharmacy technicians may prepare and dispense medicines without supervision under government proposals
News from Scotland
Pharmacy technicians could supply naloxone without prescription under government proposals
Pharmacy regulator consults on draft standards for chief pharmacists
Pharmacy First Plus expected coverage downgraded to 25% by end of 2024
RPS calls for review of the medicines supply chain in its general election manifesto
Pharmacy technicians may prepare and dispense medicines without supervision under government proposals
Scottish government to publish review of automated technology in community pharmacies
Pharmacy regulator to increase registration fees by 7.5% from April 2024
Genomics
Test yourself: the 2023 CPD and Learning quiz
Clopidogrel may be less effective in British South Asian patients, study results suggest
NICE to recommend genetic testing before prescribing clopidogrel
Pharmacogenomic testing pilot to start in general practice from June 2023
Pharmacy bodies call for pharmacists to be involved in delivery and evaluation of genomic medicines services
Should we be genetic testing before prescribing analgesics?
Infographic: 2022 unwrapped
Learning & CPD
Principles of diagnostic reasoning
How pharmacists can contribute to effective antimicrobial reviews
Lithium monitoring and toxicity management
How to talk to patients about starting antidepressants
How to diagnose and manage Trichomonas vaginalis
The effect of sea kelp on thyroid function in hypothyroidism
Epidermolysis bullosa: recognition and management
Gastrointestinal system diseases
See all-
Inflammatory bowel disease: symptoms and diagnosis
-
Inflammatory bowel disease: treatment and management
-
FDA approves two new drugs for irritable bowel syndrome
-
Antihistamine reduces pain in irritable bowel syndrome
-
Optimising therapy for inflammatory bowel disease
-
Management of patients with inflammatory bowel disease: current and future treatments
-
Management of acute upper gastrointestinal bleeding
-
Understanding irritable bowel syndrome: bugs, brains and leaky barriers
Want to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
Do antihypertensive medicines increase the risk of depression?
-
The use of insulin biobetters and biosimilars in the UK
-
Making the case for pharmacogenomics in the management of mental health conditions
-
Overview of cancer treatment-related cardiovascular toxicity
-
Errors and the inappropriate use of medicines in UK care homes
-
Clinical impact of CFTR modulator therapy roll-out